Beijing Surgerii

Beijing Surgerii Technology Co., Ltd., founded by Professor Xu Kai of Shanghai Jiao Tong University in accordance with the relevant policies of "transformation of scientific and technological achievements and independent transformation", is a high-tech enterprise with core independent intellectual property rights, mastering key technologies across the entire chain, and committed to fully independent research and development, production, and sales of general-purpose minimally invasive endoscopic surgical robot systems. Beijing Surgerii Technology Co., Ltd. holds hundreds of domestic and international patents and patent applications, establishing comprehensive independent intellectual property protection, and has successively received funding from the Ministry of Industry and Information Technology, the Ministry of Science and Technology, the Beijing Municipal Science and Technology Commission, Zhongguancun, and other government agencies at various levels, as well as support from investment institutions such as China National Investment and Development Group and Shunwei Capital.
After returning from Columbia University, Professor Xu Kai taught at Shanghai Jiao Tong University and independently developed the innovative design of the "dual continuum mechanism", overcoming the reliability and performance limitations of original continuum mechanism technology, and created the SURS single-port endoscopic surgical robot prototype with the smallest abdominal incision internationally and internationally leading comprehensive performance. Through the transformation of scientific and technological achievements at Shanghai Jiao Tong University, Beijing Surgerii incorporated the core technology of the "dual continuum mechanism" and obtained Chinese and American invention patent authorizations. Based on this, a series of key technologies were tackled, a series of core components were developed, and system integration was achieved. The high-performance deformable surgical instruments move flexibly and precisely; the 3D high-definition electronic endoscope adopts a patented design of eight-directional double-joint internal inversion and expansion, providing a wide field of view adjustment, clear and delicate imaging, and excellent color reproduction; the endoscopic surgical system performs exceptionally well in clinical use across urology, gynecology, general surgery, and thoracic surgery.
Beijing Surgerii Technology Co., Ltd. gathers outstanding scientific and technological talents from home and abroad. Before joining Surgerii, the core business team members came from well-known medical device and diagnostic equipment companies in the industry. After relentless hard work at Surgerii, they have transformed into an elite team capable of researching, developing, and producing endoscopic surgical robots. Dedicated to professional excellence and determined to innovate, completely breaking the long-term monopoly of foreign technology is the ideal and vision of Surgerii people. Upholding the corporate mission of "high-end medical equipment, independently manufactured with Chinese intelligence", Surgerii will also export original technologies to European and American markets, striving to become a global technology leader in the field of surgical robots, continuously meeting the growing demand for high-end precision medical care, and ultimately promoting the continuous development of human health and public welfare.
: